Search Results 341-350 of 13315 for monoclonal antibody

  1. Health Topics - Mayo Clinic News Network

    What's the latest on monoclonal antibody therapies to treat COVID-19? Adam Harringa. January 12, 2022. What is 'flurona' and why ...

  2. Carboplatin And Paclitaxel With Or Without Atezolizumab Before Surgery In Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer - Mayo Clinic

    Monoclonal antibodies, such as atezolizumab, may block tumor growth in different ways by targeting certain cells. Drugs used in chemotherapy, such as ...

  3. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic Staff. December 5, 2020. Monoclonal antibody treatment can help high-risk patients with COVID-19 featured image. Featured News. Monoclonal antibody ...

  4. Acute Lymphocytic Leukemia Clinical Trials - Mayo Clinic Research

    Monoclonal antibodies, such as blinatumomab, may block cancer growth in different ways by targeting certain cells. It is not yet known whether combination ...

  5. Medical Research & Education - Mayo Clinic News Network

    Monoclonal antibody therapy for COVID-19 safe for transplant patients featured image. COVID-19. Monoclonal antibody therapy for COVID-19 safe for transplant ...

  6. Telisotuzumab vedotin-tllv (intravenous route) - Side effects & uses - Mayo Clinic

    Telisotuzumab vedotin-tllv injection is a monoclonal antibody that changes the immune system to help control the growth of cancer cells. This medicine is ...

  7. Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer - Mayo Clinic

    Monoclonal antibodies, such ... No prior treatment with an immune checkpoint inhibitor (anti-PD-1, anti-PD-L1, anti-PD-L2, anti-CTLA4 monoclonal antibody).

  8. Anifrolumab-fnia (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

    It is a monoclonal antibody that changes the immune system to help control lupus symptoms. This medicine is available only with your doctor's prescription ...

  9. A Study Of TRX319 In Subjects With Primary Or Secondary Progressive Multiple Sclerosis - Mayo Clinic

    anti-CD20 monoclonal antibody (mAb) that depletes B cells, is currently. the only approved drug in the United States for primary progressive MS. (PPMS) ...

  10. Rituximab-arrx (intravenous route) - Side effects & uses - Mayo Clinic

    Rituximab-arrx is a monoclonal antibody. Rituximab-arrx injection is also used together with other medicines (eg, fludarabine and cyclophosphamide) to treat ...